CXCL9 and rheumatoid arthritis: The results indicated elevated levels of CXCL10, CXCL9, AQP9, and SPP1 in the serum of patients with RA (P < 0.05), while M1TM demonstrated lower expression in the serum of patients with RA (P < 0.05) (Supplementary Figure 7).